Zhejiang Yatai Pharmaceutical (002370.SZ) plans to establish a subsidiary to focus on exploring the development of innovative photodynamic drugs and supporting medical devices.

Zhejiang Yatai Pharmaceutical (002370.SZ) announced that, according to the development strategy and business plan needs, in order to further improve the company's industrial development layout, its wholly-owned subsidiary Yatai Li Zhong plans to establish a subsidiary named Zhejiang Shengyao Guang Research Pharmaceutical Co., Ltd. (tentative name) with its own funds of 20 million yuan. Photodynamic therapy is a medical technology that uses photosensitizers, specific wavelength light sources, and oxygen molecules to react and destroy diseased tissues. It is widely used in tumor treatment, skin diseases, and some inflammatory diseases, and is at the forefront of the current medical and health industry. The core principle is to activate the photosensitizer inside the lesion with light, generate reactive oxygen species to kill target cells, and has the characteristics of precise targeting, minimally invasive, and fast recovery. In recent years, due to the development and progress of photosensitizers, light sources, and light-guiding systems, as well as the characteristics of minimal toxic side effects and protection of organ function, photodynamic therapy has gradually become one of the important treatment methods for tumors and various benign lesions, offering unique clinical advantages in the treatment of superficial proliferative lesions on the body surface and cavities. This external investment is based on the company's strategic planning and future operational development needs, actively laying out new areas in the photodynamic industry, fully leveraging the company's existing business foundation and resource advantages, integrating resources in the field of photodynamic therapy, strengthening the research and industrialization of photodynamic drugs, focusing on exploring the development of innovative photodynamic drugs and supporting medical devices, further cultivating new business growth points for the company, optimizing business structures, enhancing overall profitability and core competitiveness, and promoting the company's long-term sustainable development.